Shanghai RAAS Blood Products Co., Ltd.
002252
Rang in aandelen
#3550
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aandeelprijs
$0.7157778
Marktkapitalisatie
$4.72B
Verandering (1 dag)
-1.44%
Verandering (1 jaar)
-23.98%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Categorie
Healthcare
Koersgeschiedenis voor Shanghai RAAS Blood Products Co., Ltd. (002252)
Hoogste slotkoers: $0.72 op 2026-10-01
Laagste slotkoers: $0.31 op 2008-06-01
Laagste slotkoers: $0.31 op 2008-06-01
Koersgeschiedenis van Shanghai RAAS Blood Products Co., Ltd. van 2008 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -10.94% |
| 2025 | -9.89% |
| 2024 | -10.82% |
| 2023 | 37.89% |
| 2022 | -19.09% |
| 2021 | -14.15% |
| 2020 | 14.88% |
| 2019 | -39.74% |
| 2018 | -42.57% |
| 2017 | -5.12% |
| 2016 | -8.73% |
| 2015 | 68.38% |
| 2014 | 1.42% |
| 2013 | 244.29% |
| 2012 | 1.81% |
| 2011 | -31.43% |
| 2010 | 83.78% |
| 2009 | 43.19% |
| 2008 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $535.90 | 25.67% |
US
|
|
| $184.77 | 588.14% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $881.33 | 8.25% |
NL
|
